Menu

Working Group

« » View all

Surveillance Workgroup Q3-2015 Update

The SRV-WG is defining the magnitude and trends of drug resistance in high burden countries, with particular focus on new and existing drugs for which resistance surveillance data are largely unavailable. Furthermore, the development of novel strategies for surveillance of TB drug resistance based on high-throughput molecular technologies will be explored.

Objectives:

3Q2015 Progress:

« » View all